Literature DB >> 16389251

Body mass index and risk for end-stage renal disease.

Chi-yuan Hsu1, Charles E McCulloch, Carlos Iribarren, Jeanne Darbinian, Alan S Go.   

Abstract

BACKGROUND: Although interest in the relationship between obesity and kidney disease is increasing, few epidemiologic studies have examined whether excess weight is an independent risk factor for end-stage renal disease (ESRD).
OBJECTIVE: To determine the association between increased body mass index (BMI) and risk for ESRD.
DESIGN: Historical (nonconcurrent) cohort study.
SETTING: A large integrated health care delivery system in northern California. PARTICIPANTS: 320,252 adult members of Kaiser Permanente who volunteered for screening health checkups between 1964 and 1985 and who had height and weight measured. MEASUREMENTS: The authors ascertained ESRD cases by matching data with the U.S. Renal Data System registry through 2000.
RESULTS: A total of 1471 cases of ESRD occurred during 8,347,955 person-years of follow-up. Higher BMI was a risk factor for ESRD in multivariable models that adjusted for age, sex, race, education level, smoking status, history of myocardial infarction, serum cholesterol level, urinalysis proteinuria, urinalysis hematuria, and serum creatinine level. Compared with persons who had normal weight (BMI, 18.5 to 24.9 kg/m2), the adjusted relative risk for ESRD was 1.87 (95% CI, 1.64 to 2.14) for those who were overweight (BMI, 25.0 to 29.9 kg/m2), 3.57 (CI, 3.05 to 4.18) for those with class I obesity (BMI, 30.0 to 34.9 kg/m2), 6.12 (CI, 4.97 to 7.54) for those with class II obesity (BMI, 35.0 to 39.9 kg/m2), and 7.07 (CI, 5.37 to 9.31) for those with extreme obesity (BMI > or = 40 kg/m2). Higher baseline BMI remained an independent predictor for ESRD after additional adjustments for baseline blood pressure level and presence or absence of diabetes mellitus. LIMITATIONS: Primary analyses were based on single measurements of exposures.
CONCLUSIONS: High BMI is a common, strong, and potentially modifiable risk factor for ESRD.

Entities:  

Mesh:

Year:  2006        PMID: 16389251     DOI: 10.7326/0003-4819-144-1-200601030-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  408 in total

1.  Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States.

Authors:  Deep Sharma; Meredith Hawkins; Matthew K Abramowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 8.237

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

Review 3.  The living kidney donor evaluation: focus on renal issues.

Authors:  Ajay Kher; Didier A Mandelbrot
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-05       Impact factor: 8.237

4.  Variability in Total Cholesterol Is Associated With the Risk of End-Stage Renal Disease: A Nationwide Population-Based Study.

Authors:  Mee Kyoung Kim; Kyungdo Han; Eun Sil Koh; Hun-Sung Kim; Hyuk-Sang Kwon; Yong-Moon Park; Kun-Ho Yoon; Seung-Hwan Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-31       Impact factor: 8.311

5.  Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.

Authors:  Shiran Udi; Liad Hinden; Brian Earley; Adi Drori; Noa Reuveni; Rivka Hadar; Resat Cinar; Alina Nemirovski; Joseph Tam
Journal:  J Am Soc Nephrol       Date:  2017-08-31       Impact factor: 10.121

6.  Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study.

Authors:  Khalid Al-Rubeaan; Amira M Youssef; Shazia N Subhani; Najlaa A Ahmad; Ahmad H Al-Sharqawi; Hind M Al-Mutlaq; Satish K David; Dhekra AlNaqeb
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

7.  Trials and Tribulations in Studying Kidney Outcomes With Intentional Weight Loss.

Authors:  Sankar D Navaneethan
Journal:  Circulation       Date:  2019-01-15       Impact factor: 29.690

Review 8.  Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease?

Authors:  Nia S Mitchell; Julia J Scialla; William S Yancy
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

9.  Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Ashley C Johnson; Lateia Taylor; Cassandra Stubbs; Alyssa Nichols; Denise C Cornelius; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

10.  Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease.

Authors:  Charumathi Sabanayagam; Tien Yin Wong; Jiemin Liao; Sunil Sethi; Boon Wee Teo
Journal:  Clin Exp Nephrol       Date:  2014-02-14       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.